GROY vs. APYX
Compare and contrast key facts about Gold Royalty Corp. (GROY) and Apyx Medical Corporation (APYX).
Performance
GROY vs. APYX - Performance Comparison
Loading graphics...
GROY vs. APYX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GROY Gold Royalty Corp. | -11.39% | 233.88% | -17.69% | -36.27% | -51.98% | 37.43% |
APYX Apyx Medical Corporation | 5.43% | 121.52% | -39.69% | 11.97% | -81.75% | 13.25% |
Fundamentals
GROY:
$803.82M
APYX:
$155.58M
GROY:
-$0.02
APYX:
-$0.27
GROY:
43.27
APYX:
2.92
GROY:
1.15
APYX:
10.70
GROY:
$15.61M
APYX:
$52.10M
GROY:
$11.81M
APYX:
$33.04M
GROY:
$6.29M
APYX:
-$5.09M
Returns By Period
In the year-to-date period, GROY achieves a -11.39% return, which is significantly lower than APYX's 5.43% return.
GROY
- 1D
- 8.48%
- 1M
- -23.34%
- YTD
- -11.39%
- 6M
- -7.25%
- 1Y
- 148.61%
- 3Y*
- 18.56%
- 5Y*
- -3.88%
- 10Y*
- —
APYX
- 1D
- 3.07%
- 1M
- 12.84%
- YTD
- 5.43%
- 6M
- 72.43%
- 1Y
- 169.34%
- 3Y*
- 8.61%
- 5Y*
- -17.68%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GROY vs. APYX — Risk / Return Rank
GROY
APYX
GROY vs. APYX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Gold Royalty Corp. (GROY) and Apyx Medical Corporation (APYX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GROY | APYX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.58 | 1.65 | +0.93 |
Sortino ratioReturn per unit of downside risk | 2.84 | 2.64 | +0.20 |
Omega ratioGain probability vs. loss probability | 1.35 | 1.31 | +0.04 |
Calmar ratioReturn relative to maximum drawdown | 3.76 | 5.05 | -1.29 |
Martin ratioReturn relative to average drawdown | 13.07 | 11.31 | +1.75 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| GROY | APYX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.58 | 1.65 | +0.93 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.07 | -0.18 | +0.11 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.01 | -0.09 | +0.09 |
Correlation
The correlation between GROY and APYX is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
GROY vs. APYX - Dividend Comparison
Neither GROY nor APYX has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
GROY Gold Royalty Corp. | 0.00% | 0.00% | 0.00% | 1.36% | 1.72% |
APYX Apyx Medical Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
GROY vs. APYX - Drawdown Comparison
The maximum GROY drawdown since its inception was -82.01%, smaller than the maximum APYX drawdown of -94.99%. Use the drawdown chart below to compare losses from any high point for GROY and APYX.
Loading graphics...
Drawdown Indicators
| GROY | APYX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.01% | -94.99% | +12.98% |
Max Drawdown (1Y)Largest decline over 1 year | -39.54% | -32.17% | -7.37% |
Max Drawdown (5Y)Largest decline over 5 years | -82.01% | -94.99% | +12.98% |
Current DrawdownCurrent decline from peak | -44.94% | -78.79% | +33.85% |
Average DrawdownAverage peak-to-trough decline | -56.15% | -56.43% | +0.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.37% | 16.25% | -4.88% |
Volatility
GROY vs. APYX - Volatility Comparison
The current volatility for Gold Royalty Corp. (GROY) is 18.65%, while Apyx Medical Corporation (APYX) has a volatility of 25.51%. This indicates that GROY experiences smaller price fluctuations and is considered to be less risky than APYX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| GROY | APYX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.65% | 25.51% | -6.86% |
Volatility (6M)Calculated over the trailing 6-month period | 43.16% | 55.45% | -12.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 57.87% | 103.25% | -45.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.37% | 98.94% | -40.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.03% | 93.04% | -33.01% |
Financials
GROY vs. APYX - Financials Comparison
This section allows you to compare key financial metrics between Gold Royalty Corp. and Apyx Medical Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GROY vs. APYX - Profitability Comparison
GROY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Gold Royalty Corp. reported a gross profit of 2.95M and revenue of 4.50M. Therefore, the gross margin over that period was 65.6%.
APYX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Apyx Medical Corporation reported a gross profit of 12.00M and revenue of 18.42M. Therefore, the gross margin over that period was 65.2%.
GROY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Gold Royalty Corp. reported an operating income of 105.00K and revenue of 4.50M, resulting in an operating margin of 2.3%.
APYX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Apyx Medical Corporation reported an operating income of 11.00K and revenue of 18.42M, resulting in an operating margin of 0.1%.
GROY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Gold Royalty Corp. reported a net income of -920.00K and revenue of 4.50M, resulting in a net margin of -20.4%.
APYX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Apyx Medical Corporation reported a net income of -1.22M and revenue of 18.42M, resulting in a net margin of -6.6%.